1. Abd-El Aziz F.M., Abdelghaffar S., Hussien E.M., Fattouh A.M.:Evaluation of cardiac functions in children and adolescents withtype 1 diabetes. J. Cardiovasc. Ultrasound., 2017; 25: 12–19 2 Abdelsamia E.M., Khaleel S.A., Balah A., Abdel Baky N.A.: Curcuminaugments the cardioprotective effect of metformin in anexperimental model of type I diabetes mellitus; Impact of Nrf2/HO-1 and JAK/STAT pathways. Biomed. Pharmacother., 2019; 109:2136–2144
2. (AT2) receptors prevents myocardial hypertrophy in Zucker diabeticfatty rats. Acta Diabetol., 2019; 56: 97–104
3. Al-Malki W.H., Abdel-Raheem I.T., Dawoud M.Z., Abdou R.F.:6-shogaol protects against diabetic nephropathy and cardiomyopathyvia modulation of oxidative stress/NF-κB pathway. Pak.J. Pharm. Sci., 2018; 31: 2109–2117
4. Andersson C., Olesen J.B., Hansen P.R., Weeke P., Norgaard M.L.,Jørgensen C.H., Lange T., Abildstrøm S.Z., Schramm T.K., Vaag A.,Køber L., Torp-Pedersen C., Gislason G.H.: Metformin treatmentis associated with a low risk of mortality in diabetic patients withheart failure: A retrospective nationwide cohort study. Diabetologia,2010; 53: 2546–2553
5. Bagul P.K., Dinda A.K., Banerjee S.K.: Effect of resveratrol on sirtuinsexpression and cardiac complications in diabetes. Biochem.Biophys. Res. Commun., 2015; 468: 221–227